Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide—targets for drug development?
- 28 February 2002
- journal article
- review article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 66 (2-3) , 193-200
- https://doi.org/10.1054/plef.2001.0357
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegenerationJournal of Neurochemistry, 2001
- Characterization of palmitoylethanolamide transport in mouse Neuro‐2a neuroblastoma and rat RBL‐2H3 basophilic leukaemia cells: comparison with anandamideBritish Journal of Pharmacology, 2001
- Anandamide activates peripheral nociceptors in normal and arthritic rat knee jointsBritish Journal of Pharmacology, 2001
- Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferensBritish Journal of Pharmacology, 2001
- Endocannabinoids control spasticity in a multiple sclerosis modelThe FASEB Journal, 2000
- Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cellsBiochemical Journal, 2000
- Unsaturated Long-Chain N-Acyl-vanillyl-amides (N-AVAMs): Vanilloid Receptor Ligands That Inhibit Anandamide-Facilitated Transport and Bind to CB1 Cannabinoid ReceptorsBiochemical and Biophysical Research Communications, 1999
- Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in LeukocytesJournal of Biological Chemistry, 1997
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- N-Acylethanolamine phospholipid metabolism in normal and ischemic rat brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986